Display options
Share it on

Can Urol Assoc J. 2011 Dec;5(6):E125-8. doi: 10.5489/cuaj.09116. Epub 2011 Jan 13.

The pattern of prostate cancer local recurrence after radiation and salvage cryoablation.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Chee Kwan Ng, Naji J Touma, Venu Chalasani, Madeleine Moussa, Donal B Downey, Joseph L Chin

Affiliations

  1. From the Division of Urology, Department of Pathology and Department of Radiology, London Health Sciences Centre, University of Western Ontario, London, ON.

PMID: 21251474 PMCID: PMC3235216 DOI: 10.5489/cuaj.09116

Abstract

OBJECTIVE: We assessed the pattern of local recurrence after salvage cryoablation of the prostate, and the impact of local recurrence on intermediate-term outcome.

METHODS: One hundred twenty-two patients who underwent salvage cryoablation were studied after a mean follow-up of 56 months. Serial prostate biopsy was carried out after cryoablation. The histopathology of prostate biopsies before and after cryoablation were compared. The prognostic value of post-cryoablation biopsy was assessed with the Cox regression method.

RESULTS: 23.1% of patients had a positive biopsy for prostate cancer following salvage cryoablation. Most cancer recurrences occurred in the apex (51.5%), base (21.2%) and seminal vesicles (18.2%). The presence of cancer at the base of the prostate was found to be a prognostic factor for eventual biochemical failure. Overall 5-year biochemical disease-free survival (bDFS) was 28%, however patients with cancer at the base of the prostate had a 5-year bDFS of 0%.

CONCLUSION: Cancer recurrences occurred in areas where aggressive freezing was avoided as it might result in serious problems (e.g., urethro-rectal fistula and incontinence). Post-cryoablation biopsies and the location of persistent disease are of prognostic value.

References

  1. J Clin Oncol. 2002 Jun 1;20(11):2664-71 - PubMed
  2. J Urol. 2001 Oct;166(4):1333-7; discussion 1337-8 - PubMed
  3. J Urol. 2007 Oct;178(4 Pt 1):1253-7; discussion 1257 - PubMed
  4. J Urol. 2008 Aug;180(2):559-63; discussion 563-4 - PubMed
  5. Eur Urol. 2003 Sep;44(3):315-20; discussion 320-1 - PubMed
  6. Tech Urol. 1996 Winter;2(4):187-93 - PubMed
  7. Cancer. 2008 Jan 15;112(2):307-14 - PubMed
  8. J Urol. 2001 Jun;165(6 Pt 1):1937-41; discussion 1941-2 - PubMed
  9. J Urol. 1999 Feb;161(2):509-14 - PubMed
  10. Urology. 1997 Nov;50(5):733-9 - PubMed
  11. J Urol. 2001 Mar;165(3):867-70 - PubMed
  12. J Urol. 1998 Mar;159(3):910-4 - PubMed
  13. J Urol. 2003 Oct;170(4 Pt 1):1199-202 - PubMed
  14. Can J Urol. 2001 Apr;8(2):1237-9 - PubMed
  15. J Urol. 2001 Nov;166(5):1707-14 - PubMed
  16. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):11-8 - PubMed
  17. Urology. 2004 Sep;64(3):551-5 - PubMed
  18. J Urol. 2003 Oct;170(4 Pt 1):1126-30 - PubMed
  19. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):468-72 - PubMed
  20. J Urol. 1997 Dec;158(6):2206-9; discussion 2209-10 - PubMed

Publication Types